Literature DB >> 2760509

An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis.

C Leport, S Bastuji-Garin, C Perronne, D Salmon, C Marche, F Briçaire, J L Vilde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2760509     DOI： 10.1093/infdis/160.3.557

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  17 in total

1.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

2.  Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.

Authors:  J Blais; C Tardif; S Chamberland
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

3.  In vitro and in vivo immunomodulatory effects of anti-Pneumocystis carinii drugs.

Authors:  M Viora; A De Luca; A D'Ambrosio; A Antinori; E Ortona
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats.

Authors:  M G Davidson; M R Lappin; J R Rottman; M B Tompkins; R V English; A T Bruce; J Jayawickrama
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

Review 5.  Human immunodeficiency virus (HIV) infection. Does it increase susceptibility to adverse drug reactions?

Authors:  G E Harb; M A Jacobson
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

6.  Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system.

Authors:  B Ruf; H D Pohle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

7.  A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.

Authors:  C U Foppa; T Bini; G Gregis; A Lazzarin; R Esposito; M Moroni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

8.  Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.

Authors:  M M París; S Shelton; M Trujillo; S M Hickey; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

9.  Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.

Authors:  B Ruf; D Schürmann; F Bergmann; W Schüler-Maué; T Grünewald; H J Gottschalk; H Witt; H D Pohle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

10.  Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition.

Authors:  J P Chave; A Munafo; J Y Chatton; P Dayer; M P Glauser; J Biollaz
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.